Impact of video-assisted thoracoscopic lobectomy versus open lobectomy for lung cancer on recovery assessed using self-reported physical function: VIOLET RCT.
Journal article
Lim E. et al, (2022), Health Technol Assess, 26, 1 - 162
Integrating genome-wide polygenic risk scores and non-genetic risk to predict colorectal cancer diagnosis using UK Biobank data: population based cohort study.
Journal article
Briggs SEW. et al, (2022), BMJ, 379
Cost-Effectiveness Analysis of Treating Patients With NTRK-Positive Cancer With the Histology-Independent Therapy Entrectinib.
Journal article
Huygens S. et al, (2022), Value Health
Antibiotic review kit for hospitals (ARK-Hospital): a stepped-wedge cluster-randomised controlled trial.
Journal article
Llewelyn MJ. et al, (2022), Lancet Infect Dis
Resource allocation in genetic and genomic medicine.
Journal article
Buchanan J. et al, (2022), J Community Genet
Can upfront DPYD extended variant testing reduce toxicity and associated hospital costs of fluoropyrimidine chemotherapy? A propensity score matched analysis of 2022 UK patients.
Journal article
Tsiachristas A. et al, (2022), BMC Cancer, 22
Can polygenic risk scores contribute to cost-effective cancer screening? A systematic review
Journal article
Dixon P. et al, (2022), Genetics in Medicine
Can polygenic risk scores contribute to cost-effective cancer screening? A systematic review
Journal article
Dixon P. et al, (2022), Genetics in Medicine
Supraglottic airway device versus tracheal intubation in the initial airway management of out-of-hospital cardiac arrest: the AIRWAYS-2 cluster RCT.
Journal article
Benger JR. et al, (2022), Health Technol Assess, 26, 1 - 158
The net benefit of personalised medicine: A systematic literature review and regression analysis.
Journal article
Vellekoop H. et al, (2022), Value in Health
Financing and Reimbursement Models for Personalised Medicine: A Systematic Review to Identify Current Models and Future Options Article
Journal article
Koleva-Kolarova R. et al, (2022), Applied Health Economics and Health Policy
Defining a Core Data Set for the Economic Evaluation of Precision Oncology.
Journal article
Pollard S. et al, (2022), Value Health
Eliciting risk preferences that predict risky health behavior: A comparison of two approaches.
Journal article
Yang M. et al, (2022), Health Econ
Video-Assisted Thoracoscopic or Open Lobectomy in Early-Stage Lung Cancer
Journal article
Lim E. et al, (2022), NEJM Evidence, 1
Cost-effectiveness of targeted genomic risk provision to prevent skin cancer: Results of a randomized trial.
Conference paper
Law CK. et al, (2022), JOURNAL OF CLINICAL ONCOLOGY, 40
WHAT IS THE NET ADDED VALUE OF PERSONALISED MEDICINE? A SYSTEMATIC LITERATURE REVIEW
Conference paper
Vellekoop H. et al, (2022), VALUE IN HEALTH, 25, S75 - S75
Utility maximization versus regret minimization in health choice behavior: Evidence from four datasets.
Journal article
Buckell J. et al, (2021), Health Econ
100,000 Genomes Pilot on Rare-Disease Diagnosis in Health Care - Preliminary Report.
Journal article
100,000 Genomes Project Pilot Investigators None. et al, (2021), N Engl J Med, 385, 1868 - 1880
Development of an intervention to support the implementation of evidence-based strategies for optimising antibiotic prescribing in general practice.
Journal article
Borek AJ. et al, (2021), Implement Sci Commun, 2
Public preferences for delayed or immediate antibiotic prescriptions in UK primary care: a choice experiment
Journal article
MORRELL E., (2021), PLoS Medicine